Abstract
About 35 years ago human papillomaviruses (HPV) have been suggested as causative agent for cervical cancer whose infectious etiology had been suggested already many years before. The discovery of the plurality of HPVs encompassing a variety of types with particular biologic properties, the regular presence of the genomes of the so called high-risk types within tumor biopsies, the awareness about the transforming potential of the viral proteins and informative epidemiological surveys led to the consenting view of a causative link between these viruses and cervical cancer and ultimately triggered the development of HPV-specific vaccines for prevention of cervical cancer.
Keywords: Papillomaviruses, heterogeneity, cervical cancer, molecular cloning, epidemiology
Current Cancer Therapy Reviews
Title: The Discovery of HPV and its Clinical Implications
Volume: 6 Issue: 2
Author(s): Lutz Gissmann
Affiliation:
Keywords: Papillomaviruses, heterogeneity, cervical cancer, molecular cloning, epidemiology
Abstract: About 35 years ago human papillomaviruses (HPV) have been suggested as causative agent for cervical cancer whose infectious etiology had been suggested already many years before. The discovery of the plurality of HPVs encompassing a variety of types with particular biologic properties, the regular presence of the genomes of the so called high-risk types within tumor biopsies, the awareness about the transforming potential of the viral proteins and informative epidemiological surveys led to the consenting view of a causative link between these viruses and cervical cancer and ultimately triggered the development of HPV-specific vaccines for prevention of cervical cancer.
Export Options
About this article
Cite this article as:
Gissmann Lutz, The Discovery of HPV and its Clinical Implications, Current Cancer Therapy Reviews 2010; 6 (2) . https://dx.doi.org/10.2174/157339410791202538
DOI https://dx.doi.org/10.2174/157339410791202538 |
Print ISSN 1573-3947 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6301 |
Call for Papers in Thematic Issues
Current progress in Protein Degradation and Cancer Therapy
argeted Protein Degradation is gaining momentum in cancer therapy, it facilitate targeting undruggable proteins, it overcome cancer resistance and avoid undesirable side effects. Thus small molecules degraders have emerged as novel therapeutic strategy. Targeted protein degradation (TPD), the process of eliminating a protein of interest hold a great promise for ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Development of Natural Bioactive Alkaloids: Anticancer Perspective
Mini-Reviews in Medicinal Chemistry Tetrazole Derivatives as Promising Anticancer Agents
Anti-Cancer Agents in Medicinal Chemistry Angiotensin-Converting Enzymes (ACE and ACE2) as Potential Targets for Malignant Epithelial Neoplasia: Review and Bioinformatics Analyses Focused in Oral Squamous Cell Carcinoma
Protein & Peptide Letters Integrins in Drug Targeting-RGD Templates in Toxins
Current Pharmaceutical Design Strategic Nanoparticle-Mediated Gene Transfer in Plants and Animals - a Novel Approach
Current Nanoscience Targeting Protein Degradation in the Nervous System
Current Medicinal Chemistry - Central Nervous System Agents Polyphenols and Aging
Current Aging Science Combinations of Plant Polyphenols & Anti-Cancer Molecules: A Novel Treatment Strategy for Cancer Chemotherapy
Anti-Cancer Agents in Medicinal Chemistry Hypoxic Tumor Microenvironment and Cancer Cell Differentiation
Current Molecular Medicine Impact of RET Screening on the Management of Multiple Endocrine Neoplasia Type 2A: 10 Years Experience and Follow-Up in Three Families
Endocrine, Metabolic & Immune Disorders - Drug Targets P2X7 Receptor Orchestrates Multiple Signalling Pathways Triggering Inflammation, Autophagy and Metabolic/Trophic Responses
Current Medicinal Chemistry Topotecan and Irinotecan in the Treatment of Pediatric Solid Tumors
Current Pediatric Reviews Analysis of Current Antifungal Agents and Their Targets within the Pneumocystis carinii Genome
Current Drug Targets RNA Sensors as a Mechanism of Innate Immune Evasion among SARSCoV2, HIV and Nipah Viruses
Current Protein & Peptide Science Antiproliferative and Pro-Apoptotic Effects of Thiazolo[3,2–b][1,2,4]triazoles in Breast and Cervical Cancer Cells
Anti-Cancer Agents in Medicinal Chemistry Editorial (Thematic Issue: Signalling Pathways in Anti-cancer Drug Resistance)
Current Medicinal Chemistry Cell Metabolism Under Microenvironmental Low Oxygen Tension Levels in Stemness, Proliferation and Pluripotency
Current Molecular Medicine Basic Mechanisms Involved in the Anti-Cancer Effects of Melatonin
Current Medicinal Chemistry Recent Findings on the Application of Toll-like Receptors Agonists in Cancer Therapy
Current Medicinal Chemistry Clearance of Beta-Amyloid in the Brain
Current Medicinal Chemistry